0.8245
Precedente Chiudi:
$0.8229
Aprire:
$0.84
Volume 24 ore:
40,249
Relative Volume:
0.18
Capitalizzazione di mercato:
$9.60M
Reddito:
$39.19M
Utile/perdita netta:
$-16.59M
Rapporto P/E:
-0.3779
EPS:
-2.182
Flusso di cassa netto:
$-9.39M
1 W Prestazione:
+13.72%
1M Prestazione:
+2.68%
6M Prestazione:
-1.83%
1 anno Prestazione:
-30.13%
Biofrontera Inc Stock (BFRI) Company Profile
Nome
Biofrontera Inc
Settore
Telefono
781-245-1325
Indirizzo
120 PRESIDENTIAL WAY,, WOBURN
Confronta BFRI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
BFRI
Biofrontera Inc
|
0.8245 | 9.59M | 39.19M | -16.59M | -9.39M | -2.182 |
|
ZTS
Zoetis Inc
|
127.17 | 55.90B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.31 | 51.72B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.91 | 44.71B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.01 | 37.30B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
RGC
Regencell Bioscience Holdings Ltd
|
45.79 | 20.48B | 0 | -5.87M | -767.30K | -0.45 |
Biofrontera Inc Borsa (BFRI) Ultime notizie
Can Biofrontera Inc. Equity Warrant stock deliver strong Q4 earningsWeekly Profit Summary & Community Consensus Trade Signals - ulpravda.ru
What Wall Street predicts for Biofrontera Inc. stock priceQuarterly Market Summary & Low Drawdown Investment Ideas - ulpravda.ru
Biofrontera Inc. Announces Data Base Locks for Two Clinical Studies Supporting Key Data and Regulatory Milestones - Sahm
Can Biofrontera Inc. Equity Warrant stock maintain growth trajectoryQuarterly Performance Summary & Real-Time Market Sentiment Reports - ulpravda.ru
Will Biofrontera Inc. stock outperform Nasdaq indexWeekly Gains Summary & Smart Swing Trading Alerts - ulpravda.ru
Can Biofrontera Inc. Equity Warrant stock outperform in 2025 bull marketPortfolio Performance Report & Fast Gain Stock Trading Tips - ulpravda.ru
Will Biofrontera Inc. Equity Warrant stock benefit from infrastructure spendingJuly 2025 Selloffs & Weekly Market Pulse Updates - ulpravda.ru
Is Biofrontera Inc. Equity Warrant stock cheap at current valuationTrade Volume Summary & Daily Oversold Bounce Ideas - ulpravda.ru
Is Biofrontera Inc. Equity Warrant stock a safe haven assetJuly 2025 Trends & Weekly Watchlist for Consistent Profits - ulpravda.ru
Biofrontera reaches database lock milestone for skin treatment studies By Investing.com - Investing.com Australia
Will Biofrontera Inc. (AI10) stock outperform value peersMarket Trend Report & AI Enhanced Trade Execution Alerts - ulpravda.ru
Why Biofrontera Inc. (AI10) stock remains stableTake Profit & Accurate Entry/Exit Alerts - ulpravda.ru
Is Biofrontera Inc. Equity Warrant stock affected by interest rate hikesInflation Watch & High Conviction Buy Zone Alerts - ulpravda.ru
Biofrontera announces data base locks for two clinical studies - TipRanks
Biofrontera completes transfer of Ameluz, RhodoLED FDA approval - MSN
Biofrontera Receives Nasdaq Notice on Bid Price Noncompliance - TipRanks
Biofrontera Received Notice of Noncompliance - TradingView — Track All Markets
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Why Baidu Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket - Sahm
Guidance Update: Can Biofrontera Inc Equity Warrant stock maintain growth trajectoryWeekly Earnings Recap & Growth Oriented Trading Recommendations - moha.gov.vn
Aug Summary: How resilient is Biofrontera Inc Equity Warrant stock in market downturnsAnalyst Upgrade & Free Accurate Trade Setup Notifications - moha.gov.vn
Retail Trends: Will Biofrontera Inc. stock split again soonJuly 2025 Summary & Weekly Top Gainers Alerts - Улправда
Is Biofrontera Inc. stock a top momentum playMarket Risk Report & Expert Verified Movement Alerts - Улправда
Will Biofrontera Inc. stock split again soonMarket Activity Report & Accurate Trade Setup Notifications - Улправда
How Biofrontera Inc. Equity Warrant stock benefits from tech adoption2025 Dividend Review & Daily Profit Maximizing Tips - Улправда
How interest rate cuts could boost Biofrontera Inc. Equity Warrant stockGlobal Markets & AI Driven Stock Reports - Улправда
Will Biofrontera Inc. stock reach all time highs in 2025Profit Target & Long Hold Capital Preservation Plans - Улправда
Why Biofrontera Inc. stock remains resilientInflation Watch & Verified Swing Trading Watchlists - Улправда
Biofrontera completes transfer of FDA approvals for Ameluz and RhodoLED By Investing.com - Investing.com South Africa
How Biofrontera Inc. stock reacts to global recession fearsGold Moves & Expert Curated Trade Setups - Улправда
Biofrontera completes transfer of FDA approvals for Ameluz and RhodoLED - Investing.com
Biofrontera completes transfer of Ameluz® and Rhodoled® FDA approval - marketscreener.com
Biofrontera Inc. Completes Transfer of Ameluz® and RhodoLED® FDA approval and Associated Intellectual Property Portfolio - The Manila Times
Biofrontera Inc. Completes Transfer of Ameluz® and - GlobeNewswire
Book value per share of Biofrontera Inc. Warrant 2021-27.10.26 on Biofrontera – NASDAQ:BFRIW - TradingView — Track All Markets
Aug Levels: Will Biofrontera Inc Equity Warrant stock split attract more investorsPortfolio Performance Summary & AI Enhanced Trading Alerts - moha.gov.vn
What analysts say about Biofrontera Inc AI10 stockContrarian Investment Ideas & Free Daily Top Stock Picks for All Investors - earlytimes.in
Biofrontera (NASDAQ:BFRI) Trading Down 1.5% – Time to Sell? - Defense World
Biofrontera Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Biofrontera completes phase 1 study for expanded Ameluz treatment areas By Investing.com - Investing.com Nigeria
Will Biofrontera Inc. (AI10) stock sustain bullish trend into 2025Market Growth Review & Risk Controlled Swing Alerts - Newser
Why Biofrontera Inc. (AI10) stock attracts HNW investors2025 Big Picture & Safe Entry Momentum Tips - Newser
Why Biofrontera Inc. (AI10) stock is favored by hedge fundsWeekly Trade Analysis & Daily Oversold Stock Bounce Ideas - Newser
Will Biofrontera Inc. Equity Warrant stock outperform growth indexes2025 Investor Takeaways & Risk Controlled Stock Pick Alerts - Newser
Biofrontera completes final patient visit in Phase 1 PK study of Ameluz gel - TipRanks
Biofrontera completes phase 1 study for expanded Ameluz treatment areas - Investing.com
Biofrontera (Nasdaq: BFRI) wraps Ameluz Phase 1 PK trial on trunk, plans 2026 FDA sNDA - Stock Titan
Biofrontera Inc Azioni (BFRI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):